Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Standard Biotools (LAB) Restructuring Costs (2022 - 2025)

Standard Biotools (LAB) has disclosed Restructuring Costs for 5 consecutive years, with -$10.5 million as the latest value for Q4 2025.

  • Quarterly Restructuring Costs fell 8469.05% to -$10.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Dec 2025, down 88.62% year-over-year, with the annual reading at $2.2 million for FY2025, 82.7% down from the prior year.
  • Restructuring Costs for Q4 2025 was -$10.5 million at Standard Biotools, down from $9.4 million in the prior quarter.
  • The five-year high for Restructuring Costs was $9.4 million in Q3 2025, with the low at -$10.5 million in Q4 2025.
  • Average Restructuring Costs over 4 years is $1.7 million, with a median of $1.7 million recorded in 2023.
  • The sharpest move saw Restructuring Costs skyrocketed 18411.11% in 2023, then crashed 8469.05% in 2025.
  • Over 4 years, Restructuring Costs stood at $9000.0 in 2022, then soared by 11788.89% to $1.1 million in 2023, then crashed by 88.22% to $126000.0 in 2024, then plummeted by 8469.05% to -$10.5 million in 2025.
  • According to Business Quant data, Restructuring Costs over the past three periods came in at -$10.5 million, $9.4 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.